Terminated PHASE4 INTERVENTIONAL 4-arm NCT01555073

Preemptive Analgesia Following Uterine Artery Embolization

A Prospective Randomized Blinded Placebo Controlled Comparison of Multimodal Pre-emptive Analgesia on Long Term Outcome Following Uterine Artery Embolization

Sponsor: Northwestern University

Conditions Uterine Artery Embolization Uterine Fibroids

Interventions Placebo group celecoxib/placebo pregabalin/celecoxib pregabalin/placebo

Updated 6 times since 2017 Last updated: Jun 29, 2016 Started: Oct 31, 2011 Primary completion: Aug 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Subjects did not meet inclusion criteria

Other terminated trials from Northwestern University

See all terminations from Northwestern University

Listed as NCT01555073, this PHASE4 trial focuses on Uterine Artery Embolization and Uterine Fibroids and remains terminated or withdrawn. Sponsored by Northwestern University, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Northwestern University

Data source: Northwestern University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States